Tech Center 1600 • Art Units: 1683
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17915167 | METHODS OF PROFILING TRANSLATION RATE | Non-Final OA | The Regents of the University of California |
| 17798506 | IMAGING AND SEQUENCING PROTEIN-DNA INTERACTIONS IN SINGLE CELLS USING INTEGRATED MICROFLUIDICS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17853256 | METHODS FOR ANALYZING SPATIAL LOCATION OF NUCLEIC ACIDS | Non-Final OA | 10x Genomics, Inc. |
| 19240318 | NEOANTIGEN IMMUNOTHERAPY | Final Rejection | Gradalis, Inc. |
| 17924640 | METHOD FOR DETECTING PARKINSON'S DISEASE | Final Rejection | JUNTENDO EDUCATIONAL FOUNDATION |
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17535204 | APPARATUS AND METHOD FOR GENE AMPLIFICATION | Final Rejection | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17767784 | USE OF SIMULTANEOUS MARKER DETECTION FOR ASSESSING DIFUSE GLIOMA AND RESPONSIVENESS TO TREATMENT | Non-Final OA | BioVentures, LLC |
| 18332359 | A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE | Non-Final OA | The Penn State Research Foundation |
| 17923700 | METHODS AND COMPOSITIONS FOR HIGH-FIDELITY SEQUENCE ANALYSIS OF INDIVIDUAL LONG AND ULTRALONG NUCLEIC ACID MOLECULES | Non-Final OA | Northeastern University |
| 18107877 | Methods and Systems for Detecting Methylation of Fragile X | Non-Final OA | Laboratory Corporation of America Holdings |
| 17560724 | COMPOSITIONS AND METHODS FOR DETECTION OF BACTERIA AND FUNGI ASSOCIATED WITH BACTERIAL AND CANDIDA VAGINOSIS | Non-Final OA | Roche Molecular Systems, Inc. |
| 17527997 | SYSTEM AND METHOD FOR SEQUENCING | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 17631908 | METHOD FOR SCREENING A SUBJECT FOR A CANCER | Final Rejection | Université de Montpellier |
| 17770974 | PROSTATE CANCER DETECTION METHODS | Final Rejection | Cancer Research Technology Limited |
| 18361797 | SYSTEM FOR PERFORMING NUCLEIC ACID AMPLIFICATION ASSAYS | Non-Final OA | GEN-PROBE INCORPORATED |
| 18289869 | ENDOCRINE TREATMENT OF HORMONE RECEPTOR POSITIVE BREAST CANCER TYPED AS HAVING A LOW RISK OF RECURRENCE | Non-Final OA | Agendia N.V. |
| 17629895 | COMPOSITIONS FOR DETECTION OF DNA AND METHODS OF USE THEREOF | Non-Final OA | Mammoth Biosciences, Inc. |
| 17863808 | METHOD FOR SYNCHRONOUSLY SEQUENCING SENSE STRAND AND ANTISENSE STRAND OF DNA | Non-Final OA | MGI TECH CO., LTD. |
| 17767788 | IMMUNE CELL QUANTIFICATION | Final Rejection | ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) |
| 18247806 | ONE OR MORE KINDS OF HLA GENE PRIMERS | Non-Final OA | H.U. Group Research Institute G.K. |
| 17762281 | SOLUBLE MEDIATORS FOR PREDICTING SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY EVENTS | Final Rejection | Oklahoma Medical Research Foundation |
| 17904394 | METHODS OF BARCODING NUCLEIC ACID FOR DETECTION AND SEQUENCING | Non-Final OA | Universal Sequencing Technology Corporation |
| 17957643 | SEQUENCING OF VIRAL DNA FOR PREDICTING DISEASE RELAPSE | Final Rejection | GRAIL, Inc. |
| 17458194 | Sample Validation for Cancer Classification | Final Rejection | GRAIL, Inc. |
| 18054676 | CELL-FREE DNA SIZE DETECTION | Non-Final OA | AccuraGen Holdings Limited |
| 17995855 | ENDOGENOUS RETROVIRUSES FOR THE DETECTION, DIAGNOSIS, AND PROGNOSIS OF CANCER | Non-Final OA | SunnyBay BioTech, Inc. |
| 17634124 | METHOD FOR DIAGNOSING BREAST CANCER | Final Rejection | Albert-Ludwigs-Universitaet Freiburg |
| 17680931 | Gene Expression Inflammatory Age and Its Uses | Non-Final OA | Edifice Health, Inc, |
| 17621552 | METHOD AND GENETIC SIGNATURE FOR DETECTING INCREASED TUMOR MUTATIONAL BURDEN | Non-Final OA | Biocartis NV |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy